keyword
https://read.qxmd.com/read/38667020/comparative-efficacy-of-continuous-ceftazidime-infusion-vs-intermittent-bolus-against-in-vitro-ceftazidime-susceptible-and-resistant-pseudomonas-aeruginosa-biofilm
#1
JOURNAL ARTICLE
Cristina El Haj, Eugènia Agustí, Eva Benavent, Laura Soldevila-Boixader, Raül Rigo-Bonnin, Fe Tubau, Benjamín Torrejón, Jaime Esteban, Oscar Murillo
Background : As the anti-biofilm pharmacokinetic/pharmacodynamic (PK/PD) properties of antibiotics are not well-defined, we have evaluated the PK/PD indices for different regimens of ceftazidime (CAZ; with/without colistin) against Pseudomonas aeruginosa biofilm. Methods : We have used the Center for Disease Control and Prevention Biofilm Reactor with two susceptible (PAO1 and HUB-PAS) and one resistant (HUB-XDR) strains of P. aeruginosa . The regimens were CAZ monotherapies (mimicking a human dose of 2 g/8 h, CAZ-IB; 6 g/daily as continuous infusion at 50 mg/L, CAZ-CI50 ; and 9 g/daily at 70 mg/L, CAZ-CI70 ) and CAZ-colistin combinations...
April 9, 2024: Antibiotics
https://read.qxmd.com/read/38667006/evolution-of-resistance-against-ciprofloxacin-tobramycin-and-trimethoprim-sulfamethoxazole-in-the-environmental-opportunistic-pathogen-stenotrophomonas-maltophilia
#2
JOURNAL ARTICLE
Luz Edith Ochoa-Sánchez, José Luis Martínez, Teresa Gil-Gil
Stenotrophomonas maltophilia is an opportunistic pathogen that produces respiratory infections in immunosuppressed and cystic fibrosis patients. The therapeutic options to treat S. maltophilia infections are limited since it exhibits resistance to a wide variety of antibiotics such as β-lactams, aminoglycosides, tetracyclines, cephalosporins, macrolides, fluoroquinolones, or carbapenems. The antibiotic combination trimethoprim/sulfamethoxazole (SXT) is the treatment of choice to combat infections caused by S...
April 5, 2024: Antibiotics
https://read.qxmd.com/read/38666999/current-epidemiological-status-and-antibiotic-resistance-profile-of-serratia-marcescens
#3
JOURNAL ARTICLE
Ilaria Cosimato, Biagio Santella, Sandra Rufolo, Paola Sabatini, Massimiliano Galdiero, Mario Capunzo, Giovanni Boccia, Veronica Folliero, Gianluigi Franci
The spread of antibiotic resistance represents a serious worldwide public health issue, underscoring the importance of epidemiology research in determining antimicrobial strategies. The purpose of this research was to investigate antibiotic resistance in Serratia marcescens isolates from clinical samples over seven years at the University Hospital "San Giovanni di Dio e Ruggi d'Aragona" in Salerno, Italy. S. marcescens is an important opportunistic pathogen associated with a wide spectrum of clinical diseases, including pneumonia, keratitis, meningitis, and urinary tract and wound infections...
April 3, 2024: Antibiotics
https://read.qxmd.com/read/38666619/sphingobium-yanoikuyae-bacteremia-japan
#4
JOURNAL ARTICLE
Yayoi Miyamatsu, Ryutaro Tanizaki, Satoko Yamada
We report a case of Sphingobium yanoikuyae bacteremia in an 89-year-old patient in Japan. No standard antimicrobial regimen has been established for S. yanoikuyae infections. However, ceftriaxone and ceftazidime treatments were effective in this case. Increased antimicrobial susceptibility data are needed to establish appropriate treatments for S. yanoikuyae.
May 2024: Emerging Infectious Diseases
https://read.qxmd.com/read/38662091/efficacy-and-safety-of-antibiotics-targeting-gram-negative-bacteria-in-nosocomial-pneumonia-a-systematic-review-and-bayesian-network-meta-analysis
#5
JOURNAL ARTICLE
David Luque Paz, Dara Chean, Pierre Tattevin, Damien Luque Paz, Betsega Assefa Bayeh, Achille Kouatchet, Delphine Douillet, Jérémie Riou
BACKGROUND: Multiple randomized controlled studies have compared numerous antibiotic regimens, including new, recently commercialized antibiotics in the treatment of nosocomial pneumonia (NP). The objective of this Bayesian network meta-analysis (NMA) was to compare the efficacy and the safety of different antibiotic treatments for NP. METHODS: We conducted a systematic search of PubMed, Medline, Web of Science, EMBASE and the Cochrane Library databases from 2000 through 2021...
April 25, 2024: Annals of Intensive Care
https://read.qxmd.com/read/38658819/high-prevalence-of-multidrug-resistant-enterobacterales-carrying-extended-spectrum-beta-lactamase-and-ampc-genes-isolated-from-neonatal-sepsis-in-ahvaz-iran
#6
JOURNAL ARTICLE
Sima Mansouri, Mohammad Savari, Arash Malakian, Effat Abbasi Montazeri
OBJECTIVES: In the recent years, multidrug resistant (MDR) neonatal septicemia-causing Enterobacterales has been dramatically increased due to the extended-spectrum beta-lactamases (ESBLs) and AmpC enzymes. This study aimed to assess the antibiotic resistance pattern, prevalence of ESBLs/AmpC beta-lactamase genes, and Enterobacterial Repetitive Intergenic Consensus Polymerase Chain Reaction (ERIC-PCR) fingerprints in Enterobacterales isolated from neonatal sepsis. RESULTS: In total, 59 Enterobacterales isolates including 41 (69...
April 24, 2024: BMC Microbiology
https://read.qxmd.com/read/38656467/genetic-diversity-of-kpc-2-producing-klebsiella-pneumoniae-complex-from-aquatic-ecosystems
#7
JOURNAL ARTICLE
Rafael da Silva Rosa, João Pedro Rueda Furlan, Lucas David Rodrigues Dos Santos, Micaela Santana Ramos, Eduardo Angelino Savazzi, Eliana Guedes Stehling
During the COVID-19 pandemic, the occurrence of carbapenem-resistant Klebsiella pneumoniae increased in human clinical settings worldwide. Impacted by this increase, international high-risk clones harboring carbapenemase-encoding genes have been circulating in different sources, including the environment. The blaKPC gene is the most commonly disseminated carbapenemase-encoding gene worldwide, whose transmission is carried out by different mobile genetic elements. In this study, blaKPC-2 -positive Klebsiella pneumoniae complex strains were isolated from different anthropogenically affected aquatic ecosystems and characterized using phenotypic, molecular, and genomic methods...
April 24, 2024: World Journal of Microbiology & Biotechnology
https://read.qxmd.com/read/38654105/what-contributes-to-the-mic-beyond-%C3%AE-lactamase-gene-detection-in-klebsiella-pneumoniae
#8
JOURNAL ARTICLE
Alyssa K W Maclean, Stacey Morrow, Fang Niu, Nancy D Hanson
BACKGROUND: K. pneumoniae is capable of resistance to β-lactam antibiotics through expression of β-lactamases (both chromosomal and plasmid-encoded) and downregulation of outer membrane porins. However, the extent to which these mechanisms interplay in a resistant phenotype is not well understood. The purpose of this study was to determine the extent to which β-lactamases and outer membrane porins affected β-lactam resistance. METHODS: MICs to β-lactams and inhibitor combinations were determined by agar dilution or E-test...
April 24, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38646622/evaluation-of-the-in-vitro-susceptibility-of-clinical-isolates-of-ndm-producing-klebsiella-pneumoniae-to-new-antibiotics-included-in-a-treatment-regimen-for-infections
#9
JOURNAL ARTICLE
Natalia Słabisz, Patrycja Leśnik, Jarosław Janc, Miłosz Fidut, Marzenna Bartoszewicz, Ruth Dudek-Wicher, Urszula Nawrot
BACKGROUND: Due to the growing resistance to routinely used antibiotics, the search for new antibiotics or their combinations with effective inhibitors against multidrug-resistant microorganisms is ongoing. In our study, we assessed the in vitro drug susceptibility of Klebsiella pneumoniae strains producing New Delhi metallo-β-lactamases (NDM) to antibiotics included in the Infectious Diseases Society of America (IDSA) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) recommendations...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38646598/novel-case-of-combination-antibiotic-therapy-for-treatment-of-a-complicated-polymicrobial-urinary-tract-infection-with-one-organism-harboring-a-metallo-%C3%AE-lactamase-mbl-in-a-pregnant-patient
#10
S Ruddy, M Bapna, K Karnik, L Yung, G Rodriguez, C Urban, J Yoon, N Prasad, S Segal-Maurer, G Turett
Carbapenem resistance due to metallo-beta-lactamases (MBLs) is a global phenomenon and an important challenge for antibiotic therapy (Boyd et al., 2020 [1]). While previous reports have demonstrated both in vitro and in vivo synergy using the combination of ceftazidime-avibactam and aztreonam against Stenotrophomonas maltophilia , an MBL-harboring organism, this treatment strategy has not been reported during pregnancy (Mojic et al., 2017 [2], [3], Mojica et al., 2016 [4], Alexander et al., 2020 [5]). We describe a 33-year-old pregnant female with polymicrobial, bilateral pyelonephritis caused by Stenotrophomonas maltophilia and other gram-negative bacteria...
2024: IDCases
https://read.qxmd.com/read/38646201/a-rare-case-of-acute-post-cataract-surgery-endophthalmitis-associated-with-achromobacter-xylosoxidans
#11
Tai Wan Dien, Nor Fariza Ngah
Achromobacter xylosoxidans is rarely reported as a causative agent of post-cataract surgery endophthalmitis. Here, we present a case where timely surgical intervention preserved the patient's vision. A 68-year-old man presented with clinical signs of endophthalmitis in his right eye three days after uneventful cataract surgery. He was initially treated with intravitreal, topical, and systemic antibiotics. After starting intravitreal, topical, and systemic antibiotics, his condition deteriorated on the second day of treatment...
March 2024: Curēus
https://read.qxmd.com/read/38643328/early-diagnosis-of-tuberculous-peritonitis-in-peritoneal-dialysis-patients-using-the-t-spot-test
#12
JOURNAL ARTICLE
Naoto Okubo, Tatsuya Suwabe, Masayuki Yamanouchi, Daisuke Ikuma, Hiroki Mizuno, Yuki Oba, Katsuyuki Miki, Takayoshi Yokoyama, Yasuo Ishii, Naoki Sawa, Yuki Nakamura, Hisashi Takaya, Yoshifumi Ubara
A 49-year-old man was admitted with peritonitis nine months after starting continuous ambulatory peritoneal dialysis (CAPD) for kidney failure. Ceftazidime and cefazolin were started. Peritoneal dialysate culture was negative for bacteria, but antibiotic treatment was continued because peritonitis improved. Twenty days later, the patient was discharged with no signs of peritonitis. However, 40-day culture of the original peritoneal dialysate detected Mycobacterium tuberculosis, and peritonitis recurred, leading to readmission...
April 21, 2024: CEN Case Reports
https://read.qxmd.com/read/38641583/virulence-antibiotic-resistance-phenotypes-and-molecular-characterisation-of-vibrio-furnissii-isolates-from-patients-with-diarrhoea
#13
JOURNAL ARTICLE
Yanyan Zhou, Li Yu, Ming Liu, Weili Liang, Zhenpeng Li, Zheng Nan, Biao Kan
BACKGROUND: Vibrio furnissii is an emerging human pathogen closely related to V. fluvialis that causes acute gastroenteritis. V. furnissii infection has been reported to be rarer than V. fluvialis, but a multi-drug resistance plasmid has recently been discovered in V. furnissii. METHODS: During daily monitoring at a general hospital in Beijing, China, seven V. furnissii strains were collected from patients aged over 14 years who presented with acute diarrhoea between April and October 2018...
April 19, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38639548/assessing-clinician-utilization-of-next-generation-antibiotics-against-resistant-gram-negative-infections-in-u-s-hospitals-a-retrospective-cohort-study
#14
JOURNAL ARTICLE
Jeffrey R Strich, Ahmed Mishuk, Guoqing Diao, Alexander Lawandi, Willy Li, Cumhur Y Demirkale, Ahmed Babiker, Alex Mancera, Bruce J Swihart, Morgan Walker, Christina Yek, Maniraj Neupane, Nathaniel De Jonge, Sarah Warner, Sameer S Kadri
BACKGROUND: The U.S. antibiotic market failure has threatened future innovation and supply. Understanding when and why clinicians underutilize recently approved gram-negative antibiotics might help prioritize the patient in future antibiotic development and potential market entry rewards. OBJECTIVE: To determine use patterns of recently U.S. Food and Drug Administration (FDA)-approved gram-negative antibiotics (ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam, plazomicin, eravacycline, imipenem-relebactam-cilastatin, and cefiderocol) and identify factors associated with their preferential use (over traditional generic agents) in patients with gram-negative infections due to pathogens displaying difficult-to-treat resistance (DTR; that is, resistance to all first-line antibiotics)...
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38638249/distribution-of-pathogenic-bacteria-and-antimicrobial-sensitivity-of-eye-infections-in-suzhou
#15
JOURNAL ARTICLE
Li Zhang, Hai-Zhang You, Guo-Hui Wang, Wei Xu, Jian-Shan Li, Qing-Liang Zhao, Shu Du
AIM: To investigate the types of bacteria in patients with eye infections in Suzhou and their drug resistance to commonly used antibacterial drugs. METHODS: The clinical data of 155 patients were retrospectively collected in this study, and the pathogenic bacteria species and drug resistance of each pathogenic bacteria were analyzed. RESULTS: Among the 155 patients (age from 12 to 87 years old, with an average age of 57, 99 males and 56 females) with eye infections (160 eyes: 74 in the left eye, 76 in the right eye and 5 in both eyes, all of which were exogenous), 71 (45...
2024: International Journal of Ophthalmology
https://read.qxmd.com/read/38635685/in-vitro-activity-of-ceftazidime-avibactam-cefiderocol-meropenem-vaborbactam-and-imipenem-relebactam-against-clinical-strains-of-the-stenotrophomonas-maltophilia-complex
#16
JOURNAL ARTICLE
Braulio Josué Méndez-Sotelo, Mónica Delgado-Beltrán, Melissa Hernández-Durán, Claudia Adriana Colín-Castro, José Esquivel-Bautista, Sandra Angélica Ortega-Oliva, Jossue Ortiz-Álvarez, Rodolfo García-Contreras, Rafael Franco-Cendejas, Luis Esau Lopez Jacome
BACKGROUND: Infections caused by Stenotrophomonas maltophilia and related species are increasing worldwide. Unfortunately, treatment options are limited, whereas the antimicrobial resistance is increasing. METHODS: We included clinical isolates identified as S. maltophilia by VITEK 2 Compact. Ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam, cefiderocol, quinolones, and tetracycline family members were evaluated by broth microdilution method and compared with first-line treatment drugs...
2024: PloS One
https://read.qxmd.com/read/38633558/antimicrobial-susceptibility-profiles-and-key-determinants-for-mortality-in-burkholderia-cepacia-complex-infections
#17
JOURNAL ARTICLE
Yusuf Emre Özdemir, Beyza Kaplan-Yapar, Deniz Borcak, Esra Canbolat-Ünlü, Osman Faruk Bayramlar, Zeynep Çizmeci, Kadriye Kart-Yaşar
OBJECTIVE: We aimed to define the clinical features and antimicrobial susceptibility profiles of Burkholderia cepacia complex infections and to determine the predictors for mortality. MATERIALS AND METHODS: Our single-center retrospective study included patients with nosocomial B. cepacia complex infection between 2018 and 2022. We evaluated the predictors of 14-day and 28-day mortality by analyzing clinical and microbiological data. RESULTS: A total of 87 patients were included...
September 2023: Infect Dis Clin Microbiol
https://read.qxmd.com/read/38631513/similar-efficacy-and-lower-cost-associated-with-ceftazidime-compared-to-tobramycin-coupled-with-vancomycin-in-antibiotic-spacers-in-the-treatment-of-periprosthetic-joint-infection
#18
JOURNAL ARTICLE
Daniel Lewis, Brenna E Blackburn, Jane Archibeck, Michael J Archibeck, Lucas A Anderson, Jeremy M Gililland, Laura K Certain, Christopher Pelt
BACKGROUND: Vancomycin and tobramycin have traditionally been used in antibiotic spacers. In 2020, our institution replaced tobramycin with ceftazidime. We hypothesized that the use of ceftazidime/vancomycin (CV) in antibiotic spacers would not lead to an increase in treatment failure compared to tobramycin/vancomycin (TV). METHODS: From 2014 to 2022, we identified 243 patients who underwent a stage I revision for periprosthetic joint infection (PJI). The primary outcome was a recurrent infection requiring antibiotic spacer exchange...
April 15, 2024: Journal of Arthroplasty
https://read.qxmd.com/read/38628240/persistent-colonization-of-ciprofloxacin-resistant-and-extended-spectrum-%C3%AE-lactamase-esbl-producing-salmonella-enterica-serovar-kentucky-st198-in-a-patient-with-inflammatory-bowel-disease
#19
JOURNAL ARTICLE
Yue Jiang, Huilin Yang, Zhen-Yu Wang, Da-Chuan Lin, Xinan Jiao, Yunlong Hu, Jing Wang
OBJECTIVE: Salmonella enterica serovar Kentucky ST198 has emerged as a global threat to humans. In this study, we aimed to characterize the prolonged carriage of ciprofloxacin-resistant and extended-spectrum β-lactamase (ESBL)-producing S . Kentucky ST198 in a single patient with inflammatory bowel disease (IBD). METHODS: Three S . Kentucky strains were collected from a single patient with IBD on 11th January, 23rd January, and 8th February, 2022, respectively...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38626002/characterization-of-%C3%AE-lactamase-and-virulence-genes-in-pseudomonas-aeruginosa-isolated-from-clinical-environmental-and-poultry-sources-in-bangladesh
#20
JOURNAL ARTICLE
Raihana Islam, Farhana Binte Ferdous, M Nazmul Hoque, Nowshad Atique Asif, Md Liton Rana, Mahbubul Pratik Siddique, Md Tanvir Rahman
The emergence and spread of multidrug-resistant pathogens like Pseudomonas aeruginosa are major concerns for public health worldwide. This study aimed to assess the prevalence of P. aeruginosa in clinical, environmental, and poultry sources in Bangladesh, along with their antibiotic susceptibility and the profiling of β-lactamase and virulence genes using standard molecular and microbiology techniques. We collected 110 samples from five different locations, viz., BAU residential area (BAURA; n = 15), BAU Healthcare Center (BAUHCC; n = 20), BAU Veterinary Teaching Hospital (BAUVTH; n = 22), Poultry Market (PM; n = 30) and Mymensingh Medical College Hospital (MCCH; n = 23)...
2024: PloS One
keyword
keyword
119136
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.